Table 5 Resistance profile of gram-positive bacteria
No | Antimicrobial agents tested | Staphylococcus aureus (n = 22, 36.7%) | CoNS (n = 15, 25.0%) | Streptococcus spp. (n = 4, 6.7%) | Enterococcus spp. (n = 12, 20.0%) | Corynebacterium striatum (n = 4, 6.7%) | Bacillus cereus (n = 3, 5.0%) | Total (n = 60) |
|---|---|---|---|---|---|---|---|---|
Resistance; n, (%) | Resistance; n, (%) | Resistance; n, (%) | Resistance; n, (%) | Resistance; n, (%) | Resistance; n, (%) | Resistance; n (%) | ||
1 | Penicillin | 19 (86.4%) | 12 (80.0%) | 0 | 4 (33.3%) | 4 (100%) | 3 (100%) | 42 (70.0%) |
2 | Oxacillin | 12 (54.5%) | 12 (80.0%) | - | - | - | - | 24 (64.9%) |
3 | Cefoxitin | 12 (54.5%) | 12 (80.0%) | - | - | - | - | 24 (64.9%) |
4 | Ampicillin | - | - | 0 | 3 (25.0%) | - | - | 3 (18.8%) |
5 | Vancomycin | 0 | 0 | 0 | 1 (8.3%) | 0 | 0 | 1 (1.67%) |
6 | Erythromycin | 9 (40.9%) | 6 (40.0%) | 0 | 6 (50.0%) | - | - | 21 (39.6%) |
7 | Tetracycline | 1 (4.5%) | 3 (20.0%) | 1 (25.0%) | 5 (41.7%) | - | - | 10 (18.9%) |
8 | Co-trimoxazole | 0 | 5 (33.3%) | 0 | - | - | - | 5 (12.2%) |
9 | Rifampicin | 0 | 0 | - | - | - | - | 0 |
10 | Moxifloxacin | 11 (50.0%) | 7 (46.7%) | - | - | - | - | 18 (48.6%) |
11 | Levofloxacin | 11 (50.0%) | 7 (46.7%) | 0 | 1 (8.3%) | - | - | 19 (35.8%) |
12 | Linezolid | 0 | 0 | - | - | - | - | 0 |
13 | Clindamycin | 8 (36.4%) | 4 (26.7%) | 0 | - | - | - | 12 (29.3%) |
14 | Gentamicin | 0 | 4 (26.7%) | - | - | - | - | 4 (10.8%) |
15 | Ciprofloxacin | 11 (50.0%) | 7 (46.7%) | - | 1 (8.3%) | 2 (50.0%) | - | 21 (39.6%) |